17 June 2020 1 Min Read
Aspen notes results of Covid-19 trial using a drug it has rights to
The drug maker has rights to dexamethasone, with preliminary results of a trial in the UK showing it can be life-saving for some Covid-19 patients
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In